Target type: molecularfunction
Binding to 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid, a straight-chain fatty acid with twenty carbon atoms and four double bonds. [GOC:ai]
5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid (5-HPETE) is a bioactive lipid mediator involved in various cellular processes, including inflammation, immunity, and cell signaling. Its binding to specific target proteins mediates these diverse functions. The molecular function of 5-HPETE binding can be described in detail as follows:
1. **Activation of Lipid Peroxidases:** 5-HPETE serves as a substrate for lipoxygenases, a class of enzymes involved in the metabolism of polyunsaturated fatty acids. Specifically, 5-HPETE is a substrate for 12/15-lipoxygenases, which further metabolize it to generate other bioactive lipid mediators like 12(S)-HETE and 15(S)-HETE. These metabolites contribute to inflammatory responses and cell signaling.
2. **Modulation of Receptor Activity:** 5-HPETE has been shown to bind to and activate G protein-coupled receptors (GPCRs), such as the formyl peptide receptor (FPR). Activation of these receptors triggers downstream signaling pathways, leading to cellular responses like chemotaxis, degranulation, and cytokine production.
3. **Regulation of Gene Expression:** 5-HPETE can directly interact with transcription factors, such as nuclear factor-kappa B (NF-κB), influencing gene expression patterns. NF-κB is a key regulator of inflammation and immune responses, and 5-HPETE's modulation of its activity can impact the expression of inflammatory genes.
4. **Induction of Apoptosis:** In certain contexts, 5-HPETE has been shown to induce apoptosis, or programmed cell death. This apoptotic effect may contribute to the resolution of inflammation and the elimination of damaged cells.
5. **Interactions with Other Biomolecules:** 5-HPETE can also interact with other biomolecules, such as proteins and lipids, to modulate their activity. These interactions contribute to its pleiotropic effects in cellular processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Oxoeicosanoid receptor 1 | An oxoeicosanoid receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q8TDS5] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
docosahexaenoate | all-cis-docosa-4,7,10,13,16,19-hexaenoic acid : A docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. docosahexaenoate : A polyunsaturated fatty acid anion that is the conjugate base of docosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. docosahexaenoic acid : Any C22 polyunsaturated fatty acid containing six double bonds. efalex: a mixture of fish oil and primrose oil; used as a high-docosahexaenoic acid fatty acid supplement | docosahexaenoic acid; omega-3 fatty acid | algal metabolite; antineoplastic agent; Daphnia tenebrosa metabolite; human metabolite; mouse metabolite; nutraceutical |
eicosapentaenoic acid | all-cis-5,8,11,14,17-icosapentaenoic acid : An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. icosapentaenoic acid : Any straight-chain, C20 polyunsaturated fatty acid having five C=C double bonds. | icosapentaenoic acid; omega-3 fatty acid | anticholesteremic drug; antidepressant; antineoplastic agent; Daphnia galeata metabolite; fungal metabolite; micronutrient; mouse metabolite; nutraceutical |
8,11,14-eicosatrienoic acid | 8,11,14-Eicosatrienoic Acid: A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5. all-cis-icosa-8,11,14-trienoic acid : An icosatrienoic acid having three cis double bonds at positions 8, 11 and 14. | fatty acid 20:3; long-chain fatty acid | fungal metabolite; human metabolite; nutraceutical |
12-hydroxy-5,8,10,14-eicosatetraenoic acid | 12-HETE : A HETE that is icosa-5,8,10,14-tetraenoic acid substituted by a hydroxy group at position 12. It is a metabolite of arachidonic acid. 12(S)-HETE : A HETE having a (12S)-hydroxy group and (5Z)-, (8Z)-, (10E)- and (14Z)-double bonds. | (5Z,8Z,10E,14Z)-12-hydroxyicosatetraenoic acid; HETE | human metabolite; pro-angiogenic agent |
5-oxo-6,8,11,14-eicosatetraenoic acid | 5-ketoeicosatetraenoic acid: a nonenzymatic rearrangement product of leukotriene A4; structure given in first source 5-oxo-ETE : An oxoicosatetraenoic acid having a 5-oxo group; and (6E)-, (8Z), (11Z)- and (14Z)-double bonds. | oxoicosatetraenoic acid | human metabolite; immunomodulator; mouse metabolite |
11,14,17-eicosatrienoate | all-cis-icosa-11,14,17-trienoic acid : An icosatrienoic acid having three cis- double bonds at positions 11, 14 and 17. | fatty acid 20:3; omega-3 fatty acid | |
5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid | (6E,8Z,11Z,13E,15S)-15-hydroxy-5-oxoicosatetraenoic acid : An icosanoid that is (6E,8Z,11Z,13E)-icosatetraenoic acid substituted at positions 5 and 15 by oxo and hydroxy groups respectively. 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid: a potent eosinophil chemotactic lipid formed by incubating human eosinophils with arachidonic acid | enone; hydroxy polyunsaturated fatty acid; icosanoid; long-chain fatty acid; oxo fatty acid; secondary allylic alcohol | human xenobiotic metabolite |